Clinical Trials in Baltimore

Showing 9921-9940 of 23,476 trials

Study in Healthy Adult Female Subjects

NCT05339633

An Open Label Phase 1 Study in Healthy Adult Female Subjects to Determine the Mass Balance Recovery, Absorption, Metabolism, and Excretion of \[14C\] D-0502 Following Single Oral Dose Administration

Mass Balance Recovery

InventisBio Co., Ltd8 participantsStarted Mar 2022

Baltimore, Maryland, United States

COMPLETEDPhase 1/2< 1 mile

An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab

NCT02754141

The purpose of this study is to assess the safety and tumor-shrinking ability of experimental medication BMS-986179 alone and when combined with Nivolumab, in patients with solid cancers that are advanced or have spread.

Malignant Solid Tumor

Bristol-Myers Squibb235 participantsStarted Jun 2016

Chicago, Illinois, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +21 more locations

Study in Healthy Adult Female Subjects

An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab

Find Trials by Condition in Baltimore

Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Validation of a Novel Cortical Biomarker Signature for Pain

Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device (PCD)

Providing Unique Support for Health (PUSH) Study

Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia

The PCOS Challenge Study

Raltegravir for HAM/TSP

S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction

Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism

A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis